HDCN is divided into a FREE ZONE and a KEY ZONE. The latter is open only to paid subscribers. The FREE ZONE is open to all who have registered and contains symposia where sponsorship of a professional society or company was obtained to defray costs of preparation, storage, and file transfer charges. Currently the FREE ZONE symposia on HDCN are as follows:
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD). Rebecca Schmidt, DO, FACP, FASN and Sharon Senft, RN-C, FNP
(ANNA National Symposium, April, 2008.)
Stabilizing Hemoglobin Levels: What’s New in IV Iron and Anemia Management? Steven Fishbane, MD; Suzann VanBuskirk, BSN, RN, CNN, and Kristin Larson, RN, ANP, GNP, CNN
(ANNA National Symposium, April, 2008.)
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease Wajeh Qunibi, MD, FACP and Lynda Szczech, MD, MSCE
(ANNA National Symposium, April, 2008.)
Achieving Control: Optimizing the Management of CKD-Anemia Allen R. Nissenson, MD; Steven Fishbane, MD; Michael J. Germain, MD; Robert Provenzano, MD
(CME Symposium (Synermed-Penn State), March, 2008.)
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 Wajeh Qunibi, MD, and Charles Nolan, MD
(CME Symposium (Medical Education Resources), January, 2008.)
Medical Crossfire: Managing Phosphorus in CKD -- The Challenge Remains David Bushinsky, MD (moderator); Geoffrey Block, MD, CCRI; Francisco Llach, MD; Rajnish Mehrotra, MD, FACP, FASN. (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions Gérard M. London, MD (moderator); Craig B. Langman, MD; Markus Ketteler, MD. (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction John C. Burnett, MD; Michael B. Fowler, MBBS, FRCP, FACC; Mihai Gheorghiade, MD. (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis Norbert Lameire, MD (moderator); Pontus B. Persson, MD, PhD; Michael V. Knopp, MD, PhD; Mark A. Perazella, MD (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
New Developments in Anemia Management in Chronic Kidney Disease Dr. Adeera Levin, MD (moderator): Cindy Roy, PhD; Anatole Besarab, MD; Richard Amerling, MD, Arnold Berns, MD (discussant). (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia Jeffrey S. Berns, MD, FASN; Robert Provenzano, MD; Lynda Szczech, MD. (Moderator: Jeffrey S. Berns, MD) (Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007)
Chronic Kidney Disease - Mineral Bone Disorder (Jose A.L. Arruda, MD, FACP; Jennifer L. Snavely, CRNP-BC, MSN, CNN) Target audience: Nurses. ANNA National Symposium, April 2007)
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease Sally Burrows-Hudson, MS, RN, CNN; Carol Headley, DNSc, RN, CNN; Sally Campoy, DNP(c), MS, APRN, BC. (Target audience: Nurses. ANNA National Symposium, April 2007)
Achieving and Maintaining a Phosphate Balance in the Patient With CKD. Terran Mathers, DNS, RN. (Target audience: Nurses. ANNA National Symposium, April 2007)
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease. Jay B. Wish, MD; William M. McClellan, Jr, MD; Richard A Lafayette, MD. (RPA Satellite Symposium, March, 2007).
Iron Deficiency Anemia in Various Patient Populations. Iron Management Considerations. Joanna Hudson, PharmD. (Target audience - Pharmacists. Medical Education Resources. February, 2007).
Bone and Mineral Metabolism in CKD: Medical Crossfire. Hartmut H. Malluche, MD; Stuart M. Sprague, DO; Dennis L. Andress, MD (Moderator: Peter Salgo, MD). (ASN Renal Week Official Symposium. November, 2006)
Fluid Dysregulation: Disturbances and Management Robert W. Schrier, MD; Arthur Greenberg, MD. (ASN Renal Week Official Symposium. November, 2006)
Managing CMV Infections in Transplantation Robert S. Gaston, MD; Daniel C. Brennan, MD. (Moderator: David Roth, MD). (ASN Renal Week Official Symposium. November, 2006)
Inflammation in CKD: Biomarkers, Morbidity and Therapy George A. Kaysen, MD, PhD; Mark J. Sarnak, MD; Peter Stenvinkel, MD, PhD. (ASN Renal Week Official Symposium. November, 2006)
The CKD that Follows Renal Transplantation: How to Best Manage these Patients Anil Chandraker, MD, and Warren L. Kupin, MD. (Moderator: Gabriel Danovitch, MD). (ASN Renal Week Official Symposium. November, 2006)
The New KDOQI Guidelines for Anemia; A Debate: Should an Upper Hgb Limit be Set and What Should it Be? Allen R. Nissenson, MD and Daniel W. Coyne, MD. (Moderator: Brian J.G. Pereira, MD). (ASN Renal Week Official Symposium. November, 2006)
Lupus Nephritis: Defining and Treating Renal Flares Ronald J. Falk, MD and Gerald B. Appel, MD. (ASN Renal Week Official Symposium. November, 2006)
New, Tri-Partite Approach to Anemia (John W. Adamson, MD; Stephen Fishbane, MD; Ajay K. Singh, MB, FRCP; Moderator: Jay B. Wish, MD.) (ASN Renal Week Official Symposium. November, 2006)
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease (Robert N. Foley, MB; Domenic A. Sica, MD. (Moderator: Patrick S. Parfrey, MD) (ASN Renal Week Official Symposium. November, 2006)
Anemia Management in CKD: Improving Iron Management (ANNA National Meeting, April, 2006)
Evidence-based Anemia Management (ANNA National Meeting, April, 2006)
A Balanced Approach to Anemia Therapy: IV Iron and EPO. (ANNA National Meeting, April, 2006)
Practical Considerations for the Management of Anemia in Nephrology Patients: Searching for an Improved Erythropoietic Treatment. (RPA Satellite Symposium, Released July, 2006)
Resistant Hypertension: Reducing Cardiovascular Events (ASN Renal Week 2005 Official Symposium. November, 2005)
Transplantation: Key Issues for the General Nephrologist (ASN Renal Week 2005 Official Symposium. November, 2005)
Post-Transplant Infections: Updating the General Nephrologist (ASN Renal Week 2005 Official Symposium. November, 2005)
Medical Crossfire: An Expert Panel Debates Key Clinical Issues in Mineral Metabolism and Mortality in CKD. (ASN Renal Week 2005 Official Symposium. November, 2005)
Anemia in Renal Disease: Update and Case Discusion (ASN Renal Week 2005 Official Symposium. November, 2005)
Current Concepts in Neurohormones: Vasopressin and the Kidney (ASN Renal Week 2005 Official Symposium. November, 2005)
The Role of Iron Deficiency in Anemia Management: Key Controversies (ASN Renal Week 2005 Official Symposium. November, 2005)
Anemia and Iron Management: Addressing Challenges and Generating Solutions. (ANNA Fall Meeting Satellite Symposium - September 25, 2005 )
Complications of Anemia and the CKD Patient (ANNA CE Satellite Symposium. April, 2005 )
Treating Patients With IV Iron Therapy: Special Considerations (ANNA CE Satellite Symposium - Las Vegas, Nevada, April 21, 2005)
Maximizing Patient Outcomes Through IV Iron Therapy and Appropriate Iron Measures (A CME Symposium at the Renal Research Institute 7th International Conference on Dialysis: Advances in ESRD 2005; New Orleans, January, 2005.)
Caring Through the End: Palliative Care Along the Continuum of CKD (Mid-Atlantic Renal Coalition, Orlando, FL. December, 2004)
Cardiovascular Disease in CKD: Strategies for Reducing Risk (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
Infections and Renal Complications of Immunosuppression: An Update (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
Emerging Data on Iron Management: Clinical Implications (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
CKD and CHF: the Silent Threat (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
Meeting the K/DOQI Mineral and Bone Guidelines in CKD (Stages 3 and 4): The Essential Role of Vitamin D (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
Patients with CKD: Preventing the Complications of Mineral and Metal Accumulation in a Closed System (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
AA Amyloidosis: Diagnosis and Management (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
Evolving Strategies for Renoprotection: From ACEI to Enzyme Replacement Therapy (ERT) Fabry's Disease: The Nephrologist Perspective (ASN Renal Week 2004 Official Symposium. St. Louis, MO. October, 2004)
Towards Better Control in CKD: Improving Anemia Management (target audience: Nurses; free CE) -- (ANNA Fall Clinical Practice Sessions, New Orleans, LA; October, 2004)
Secondary Hypertension, including Chronic Kidney Disease (ASN Board Review Course, San Francisco, August, 2004)
Phosphorus-PTH-Bone: Achieving Balance and Avoiding Extraosseous Calcification (ASN Renal Week, San Diego; November, 2003)
Addressing Current Challenges & Clinical Implications In Iron Management (ASN Renal Week, San Diego; November, 2003)
A Novel Approach to Controlling Secondary Hyperparathyroidism (HPT): Targeting the Calcium-Sensing Receptor (ASN Renal Week, San Diego; November, 2003)
Intravenous Iron Management for Pharmacists: Safety, Efficacy, Dosing and Pharmacoeconomic Considerations (Pharmacist CE Symposium, December, 2003)
Vitamin D and the Prevention of Morbidity and Mortality in Dialysis Patients(Four Talks and Discussion) (ASN Renal Week, San Diego; November, 2003)
Viral Diseases and Renal Transplantation(Four Talks and Discussion) (ASN Renal Week, San Diego; November, 2003)
Morbidity & Motality Across the CKD Continuim: Can A Renewed Focus on Anemial Improve Outcomes? (Four Talks and Discussion) (ASN Renal Week, San Diego; November, 2003)
Mycophenolate Mofetil: Emerging Role in Glomerular Disease (Four Talks and Discussion) (ASN Renal Week, San Diego; November, 2003)
Chronic Kidney Disease: Emerging Strategies for Managing the Cardio-Renal Syndrome (Four Talks and Discussion) (ASN Renal Week, San Diego; November, 2003)
Making Sense: A Scientific Approach to IV Iron (Three Talks and Discussion) (ASN Renal Week, San Diego; November, 2003)
Addressing the Ongoing Clinical Debate: Implications of Iron Therapy (A Kidney Learning (KIS) Program)
Best Nursing Practices for Central Venous Hemodialysis Catheters (Three Talks) (ANNA Satellite Symposium, April, 2003 )
Focus on the Future: Realities, Challenges, Solutions (ANNA National Symposium, April, 2003)
Options and Issues in Anemia Management (Four talks) (ANNA Lunch Symposium, April, 2003)
IV Iron: Patients & Professionals in Dialogue: Addressing Concerns of Hemodialysis Patients (ANNA Breakfast Symposium, Chicago; April, 2003)
Development of Hemodialysis: From Access to Machines (Dorab Patel Memorial Lecture, October, 2002)
Practical Management of Secondary Hyperparathyroidism: From Basic Science to Clinical Medicine (ASN Official Evening Symposium, Philadelphia, PA. November, 2002)
Improving Outcomes in High-Risk Patients with Hypertension (ASN Satellite Symposium, Philadelphia, PA. November, 2002)
Current Iron Deficiency in CKD: Challenges/Controversies (ASN Satellite Symposium, Philadelphia, PA. November, 2002)
Executing Change in the Management of Chronic Kidney Disease (ASN Official Evening Symposium, Philadelphia, PA. November, 2002)
Modern Approaches to Anemia Management: Current Models for Clinical and Practice Operation Success. (ASN Satellite Symposium, Philadelphia, PA. November, 2002)
Emerging Standards of Care: Implications of New K/DOQI Guidelines (ASN Satellite Symposium, Philadelphia, PA. November, 2002)
Iron at the Front Lines: A Practical Approach to IV Iron Management (ANNA Satellite Symposium, Orlando, FL. May, 2002)
Taking Control of Chronic Kidney Disease: Beyond the Kidney (ANNA Satellite Symposium, Orlando, FL. May, 2002)
Improving Vascular Access Outcomes Using an Innovative Subcutaneous Access System (3 talks) (ANNA Satellite Symposium, Orlando, FL. May, 2002)
Caring for the Renal Failure Patient: Optimizing Iron Therapy (3 talks, panel) (ANNA Satellite Symposium, Orlando, FL. May, 2002)
The Advancement of Clinical Practice in Chronic Kidney Disease (RPA Satellite Symposium, Washington, DC. March, 2002)
Cardiac Calcification in ESRD: New Information Revealed (ASN/ISN Satellite Symposium, San Francisco, CA, October, 2001)
Current Implications of Abnormal Bone Pathology: Consequences and Therapy (ASN/ISN Satellite Symposium, San Francisco, CA, October, 2001)
The Evolution of Chronic Kidney Disease: Defining a Model for Care (ASN/ISN Evening Symposium, San Francisco, CA, October, 2001)
New Therapies for Anemia Management in CKD: An Interactive Symposium (ASN/ISN Evening Symposium, San Francisco, CA, October, 2001)
Global Management of Chronic Renal Insufficiency. Practical Issues. (ASN/ISN Evening Symposium, San Francisco, CA, October, 2001)
Managing Intradialytic Hypotension: A Clinical Challenge. (ASN/ISN Evening Symposium, San Francisco, CA, October, 2001)
Polycystic Liver in PKD; Pain Management in PKD (Annual PKD Foundation Meeting, Chicago, IL, June, 2001)

See also a list of Slide/Audio Symposia by Topic


KEY ZONE
The symposia on HDCN where no sponsorship was obtained, or where sponsorship was obtained but where the symposia have been posted for more than 1 year, are in the KEY ZONE. Please support HDCN and obtain a paid subscription to access all of this other content.
 
HDCN HOME